Pakistan has over 800 pharmaceutical companies, which have the potential to significantly boost the country's exports. Last year, India exported $26 billion worth of pharmaceuticals, while Pakistan ...

They should question Kennedy directly about his views on forcibly relicensing patents — and upending America's entire ...

Democrats responded to Donald Trump's repeal of Biden executive orders aimed at lowering prescription drug prices and ...

Eleven drugs are poised to reach blockbuster status, dramatically improving patient outcomes on a global scale.

Drug developer Maze Therapeutics said on Monday it was targeting a valuation of up to $728.1 million in its New York initial ...

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year. The ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

The companies took issue with the agency’s latest findings, contending that their practices reduce drug costs. “Optum is lowering the cost of specialty medications, which comprises half of all ...

The FTC also said these so-called Big Three health care companies — which it estimates administer 80% of all prescriptions in the U.S. — are inflating drug prices “at an alarming rate ...

Merck CEO Rob Davis told CNBC's Jim Cramer that there's more to the pharmaceutical giant than ... pipeline is the most diversified in the company's recent history, with its portfolio is broadening ...

Advancements in targeted therapies have transformed the treatment landscape for NSCLC, enabling precision medicine approaches that improve outcomes. These therapies focus on specific genetic ...